Respiratory Syncytial Virus Diagnostic Testing Market - Forecast(2021 - 2026)

Report Code: HCR 0826 Report Format: PDF + Excel (Delivery in 48 Hrs)

Respiratory Syncytial Virus Diagnostic Testing Market Overview

Respiratory Syncytial Virus Diagnostic Testing Market size was valued at $14.2 billion by 2020, and is anticipated to grow at a CAGR of 10.8% during the forecast period 2021-2026. The Respiratory Syncytial Virus Diagnostic Testing Industry growth rate is attributed to the increased RSV infection burden, increased demand for Point-of-Care(POC) molecular diagnostic tests to diagnose RSV infections, and increased approval of diagnostic kits and assays for RSV are anticipated to bring new opportunities. A virus that commonly causes infection of the lower respiratory tract is the Respiratory Syncytial Virus (RSV). Respiratory Syncytial Virus Diagnostics Market include direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others. In premature babies and children up to five years of age, RSV is an important cause of severe respiratory illness. Its symptoms can range from bronchiolitis and pneumonia to a mild cold-like illness. According to the U.S. Centre for Disease Control and Prevention (CDC), RSV is the common cause of bronchiolitis or pneumonia in the children under one year of age in the United States. Each year 75,000 to 125,000 children are hospitalized due to RSV infections. In addition, there is a growing need for fast, specific and sensitive diagnostic techniques as the clinical symptoms of RSV infections are indistinguishable from other respiratory infections. The current shortage of specific treatment options and the future development of RSV vaccines are the main constraints facing this market.

Respiratory Syncytial Virus Diagnostic Testing Market Report Coverage

The report: “Respiratory Syncytial Virus Diagnostic Testing Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Fruit Pomace Utilisation Market:

By Product Type: Kits and Assays, Instruments and Others.

By Diagnostic Technology: Direct Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test (RADTS), Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Micro-droplets, Flow Cytometry and Others.

By End Use: Hospitals and Clinics, Clinical Laboratories, Home Care and Others.

By Geography: North America (U.S, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Others), APAC (China, Japan India, Australia and Others), and RoW (Middle East, South America and Africa).

Key Takeaways

  • North America dominated the Respiratory Syncytial Virus Diagnostic Testing Market with a share of 42.2% in the year 2020. 
  • The factors such as increasing incidence rate of respiratory infections; rising neonatal population base, increasing demand for in-vitro diagnostics, and increasing demand for point of care facilities are amongst the major factor projected to impel growth of Respiratory Syncytial Virus Diagnostic Testing Market.
  • With rising incidences of chronic conditions worldwide, cases of respiratory infections are anticipated to increase is the key factors owing the growth in the segment during forecast period 2021-2026.

Respiratory Syncytial Virus Diagnostic Testing Market Segment Analysis - By Diagnostic Technology

On the basis of diagnostic technology, molecular diagnostics segment held the highest segmental revenue share in 2020. This can be attributed to the fact that high accuracy of molecular methods over other methods. Furthermore, this method is a gold standard for RSV diagnosis, as it is the most accurate method.

On the contrary, Rapid Antigen Diagnostic Test (RADT) segment is anticipated to witness significant growth along the forecast period 2021-2026 owing to advantages such as quick result time, elimination of ancillary testing, early diagnostic and implementation of treatment, and improving antibiotic stewardship. Moreover, this test detects infected patients early in the course of action, which leaves a positive impact on clinical decisions.

Global Respiratory Syncytial Virus Diagnostic Testing Market, By Diagnosis Technology 2020(%)

 

Respiratory Syncytial Virus Diagnostic Testing Market Segment Analysis - By  End-Use

On the basis of end-use, hospitals and clinics segment accounted for the largest segmental revenue of the Respiratory Syncytial Virus Diagnostic Testing market in 2020 as the occurrence of RSV infection is prominent in neonates and infants, the treatment for these demographics has to be controlled with round-the-clock monitoring. Hence there is high hospitalization in case of RSV infection and is anticipated to stimulate market growth during the forecast period 2021-2026.

However, home care is poised to hold the highest growth rate with a CAGR of 10.9 %over the forecast period 2021-2026. This is owing to the facts that home healthcare is a cost-effective alternative over the hospital stay. Moreover, the availability of adequate trained staff for home healthcare is expected to support the growth of home healthcare in the RSV diagnostics market.

Respiratory Syncytial Virus Diagnostic Testing Market Segment Analysis - By  Geography

North America is the major region dominating the Respiratory Syncytial Virus Diagnostic Testing market with a market share of 42.16% in the year 2020. This can be attributed to the rising incidences of these infections and an increasing infant population over the forecast period 2021-2026. In order to produce companion diagnostics, increasing the number of strategic partnerships between pharmaceutical majors and in vitro diagnostic manufacturing companies are anticipated to make this a lucrative segment by signaling tremendous potential that could also be responsible for fueling the global RSV diagnostic testing market in the region.

However, Asia Pacific is projected to be the significant-growing market during the forecast period 2021-2026 owing to the high population density and rapidly increasing prevalence of infectious diseases. Strong demand for automated healthcare testing for accurate and faster diagnosis of the diseases is poised to boost the market growth in the region. China, India, Japan, and Malaysia are expected to be the fastest-growing markets in the region due to the developing healthcare systems and growing numbers of government initiatives. Furthermore, the rising infant population is anticipated to propel the growth of the market.

Respiratory Syncytial Virus Diagnostic Testing Market Drivers

Increasing Burden of Respiratory Syncytial Virus (RSV) Infections

The RSV diagnostic testing market is poised to receive an upswing owing to rising incidences of childhood pneumonia are also predicted to propel the demand for RSV testing. According to statistics provided by the WHO, about 151.8 million cases of childhood pneumonia were recorded in 2001 in developing countries such as Latin America. It also estimated that about 1.9 million of these cases led to death.

Respiratory Syncytial Virus Diagnostic Testing Market Challenges

COVID-19 Related Production and Supply Chain Disruptions

Despite several drivers, the impacts of COVID-19 are fast-moving in the food processing industry in general and in the RSV testing market in particular. This market is a linked network of production of kits, assays, instruments, and others. The domino effect of the global pandemic's factory closures and logistical delays reveal the fragility of access to RSV diagnostic products which in turn is poised to impact the revenue growth in 2020.

Respiratory Syncytial Virus Diagnostic Testing Industry Outlook

Product launches, mergers, and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Respiratory Syncytial Virus Diagnostic Testing Market. In 2020, Respiratory Syncytial Virus Diagnostic Testing Market share is fragmented by the top ten players present in the market. Respiratory Syncytial Virus Diagnostic Testing Market top 10 companies are F. Hoffmann La-Roche AG , Becton, Dickinson and Company, Novartis AG, Abbott Laboratories, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., BioMerieux, DiaSorin SPA, Millipore-sigma, Quidel Corporation, Alere Inc., Coris BoConcept, Fast-track Diagnostics and others.

Acquisitions/Product Launches

  • In May 2019, QIAGEN N.V. received 510 (k) clearance from the US Food and Drug Administration (FDA) for its QIAstat-Dx syndromic testing system.

Relevant Reports:

Respiratory Disease Testing/Diagnostics Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2020 – 2025.

https://www.industryarc.com/Research/Respiratory-Disease-Testing-Diagnostics-Market-Research-503770

Respiratory Devices Market - Forecast(2021 - 2026)

https://www.industryarc.com/Report/16227/respiratory-devices-market.html


 For more Lifesciences and Healthcare Market reports, please click here

1. Respiratory Syncytial Virus Diagnostic Testing Market Overview
    1.1 Definitions and Scope
2. Respiratory Syncytial Virus Diagnostic Testing Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Diagnostics Technology
    2.3 Key trends by End Use
    2.4 Key trends by Geography
3. Respiratory Syncytial Virus Diagnostic Testing Market – Comparative Analysis
    3.1 Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Patent Analysis
    3.4 Average Pricing Analysis
4. Respiratory Syncytial Virus Diagnostic Testing Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Respiratory Syncytial Virus Diagnostic Testing Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Respiratory Syncytial Virus Diagnostic Testing Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Respiratory Syncytial Virus Diagnostic Testing Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Respiratory Syncytial Virus Diagnostic Testing Market – By Product Type (Market Size –$Million/$Billion)
    8.1 Kits and Assays
    8.2 Instruments
    8.3 Others
9. Respiratory Syncytial Virus Diagnostic Testing Market – By Diagnostic Technology (Market Size –$Million/$Billion)
    9.1 Molecular Diagnostics
    9.2 Direct Fluorescent Antibody (DFA) Method
    9.3 Rapid Antigen Diagnostic Test
        9.3.1 Enzyme-Linked Immunosorbent Assays
        9.3.2 Immunofluorescence Assays
        9.3.3 Other Rapid Antigen Detection Tests
    9.4 Monoclonal Antibodies
    9.5 Flow Cytometry
    9.6 Diagnostic Imaging
    9.7 Immnunochromgraphic Assay
    9.8 Gel Microdroplets
    9.9 Others
10. Respiratory Syncytial Virus Diagnostic Testing Market – By End Use (Market Size –$Million/$Billion)
    10.1 Hospitals and Clinics
    10.2 Clinical Laboratories
    10.3 Home Care
    10.4 Others
11. Respiratory Syncytial Virus Diagnostic Testing Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Respiratory Syncytial Virus Diagnostic Testing Market - Entropy
13. Respiratory Syncytial Virus Diagnostic Testing Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Respiratory Syncytial Virus Diagnostic Testing Market – Key Company List by Country Premium Premium
15. Respiratory Syncytial Virus Diagnostic Testing Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.